Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;11(3):545-553.
doi: 10.1111/jdi.13164. Epub 2019 Nov 6.

Transplantation of adipose-derived mesenchymal stem cell sheets directly into the kidney suppresses the progression of renal injury in a diabetic nephropathy rat model

Affiliations

Transplantation of adipose-derived mesenchymal stem cell sheets directly into the kidney suppresses the progression of renal injury in a diabetic nephropathy rat model

Shunsuke Takemura et al. J Diabetes Investig. 2020 May.

Abstract

Aims/introduction: Adipose-derived mesenchymal stem cell (ASC) transplantation is a promising therapy for diabetic nephropathy (DN). However, intravascular administration of ASCs is associated with low engraftment in target organs. Therefore, we considered applying the cell sheet technology to ASCs. In this study, ASC sheets were directly transplanted into the kidneys of a DN rat model, and therapeutic consequences were analyzed.

Materials and methods: Adipose-derived mesenchymal stem cells were isolated from adipose tissues of 7-week-old enhanced green fluorescent protein rats, and ASC sheets were prepared using a temperature-responsive culture dish. A DN rat model was established from 5-week-old Spontaneously Diabetic Torii fatty rats. Seven-week-old DN rats (n = 21) were assigned to one of the following groups: sham-operated (n = 6); ASC suspension (6.0 × 106 cells/mL) administered intravenously (n = 7); six ASC sheets transplanted directly into the kidney (n = 8). The therapeutic effect of the cell sheets was determined based on urinary biomarker expression and histological analyses.

Results: The ASC sheets survived under the kidney capsule of the DN rat model for 14 days after transplantation. Furthermore, albuminuria and urinary tumor necrosis factor-α levels were significantly lower in the ASC sheets transplanted directly into the kidney group than in the sham-operated and ASC suspension administered intravenously groups (P < 0.05). Histologically, the ASC sheets transplanted directly into the kidney group presented mild atrophy of the proximal tubule and maintained the renal tubular structure.

Conclusions: Transplantation of ASC sheets directly into the kidney improved transplantation efficiency and suppressed renal injury progression. Therefore, the ASC sheet technology might be a promising novel treatment for DN.

Keywords: Adipose-derived mesenchymal stem cell; Cell sheet; Renal injury.

PubMed Disclaimer

Conflict of interest statement

Tatsuya Shimizu was a member of the scientific advisory board and a shareholder of CellSeed, Inc. Tokyo Women’s Medical University received research funding from CellSeed, Inc. The other authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the experimental procedure for transplanting adipose‐derived mesenchymal stem cell (ASC) sheets into diabetic nephropathy rats. (a) ASCs were isolated from epididymal adipose tissue of enhanced green fluorescent protein rats (scale bar, 30 μm). Macro image of fabricated ASC sheet: (b) bright field and(c) dark field. (d) The ASC sheets were directly transplanted into the kidney of a diabetic nephropathy rat model. (e) Macro image of the kidneys immediately after transplantation. Diabetic nephropathy rats (aged 7‐weeks‐old) were randomly divided into three groups. Urine samples were collected on 0, 7 and 14 days after transplantation, and rats were killed 14 days after transplantation. (f) Red line: after transplantation.
Figure 2
Figure 2
Characteristics of adipose‐derived mesenchymal stem cell (ASCs). ASCs were confirmed on the basis of colony formation, adipogenesis and osteogenesis. (a) They were stained with crystal violet to confirm colony formation. (b) The fourth passage ASCs were stained with Oil Red O to detect adipogenesis (scale bar, 50 μm). (c) They were stained with alizarin red S to detect osteogenesis (scale bar, 50 μm). (d–h) Cell surface markers of mesenchymal stem cells were evaluated using flow cytometry. The surfaces of ASCs were positive for CD29 and CD90 and negative for CD11b, CD31 and CD45
Figure 3
Figure 3
Adipose‐derived mesenchymal stem cell (ASC) sheets directly transplanted into the kidney survived for 14 days. Macro image of the kidney 14 days after transplantation: (a) bright field and (b) dark field. Immunohistochemical image of the kidney 14 days after transplantation: (c) ASC i.v. group and (d) ASC sheet group (scale bar, 50 μm). GFP, green fluorescent protein.
Figure 4
Figure 4
Adipose‐derived mesenchymal stem cell (ASC) sheets suppressed glomerular injury. (a,b) Change in albuminuria and proteinuria after transplantation. White circles, sham group; black triangles, ASC i.v. group; white squares, ASC sheet group. (c) Urinary podocalyxin levels 14 days after transplantation. Data are presented as the mean ± standard error of the mean (n = 6–8/group); *P < 0.05.
Figure 5
Figure 5
Adipose‐derived mesenchymal stem cell (ASC) sheets suppressed renal tubular injury. The renal cortex of each group, 14 days after transplantation, was stained with the periodic acid/Schiff base. Representative images are shown. (a–c) Low magnification (scale bar, 500 μm). (d–f) High magnification (scale bar, 50 μm). (g,h) Levels of urinary L‐FABP and KIM‐1 14 days after transplantation. Data are presented as the mean ± standard error of the mean (n = 6–8/group); *P < 0.05.
Figure 6
Figure 6
Adipose‐derived mesenchymal stem cell (ASC) sheets suppressed chronic inflammation in the kidney. (a,b) Levels of urinary tumor necrosis factor‐α (TNF‐α) and interleukin‐6 (IL‐6) 14 days after transplantation. Data are presented as mean ± standard error of the mean (n = 6–8/group); *P < 0.05.

References

    1. Dronavalli S, Duka I, Bakris GL. The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 2008; 4: 444–452. - PubMed
    1. Kanwar YS, Sun L, Xie P, et al. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 2011; 6: 395–423. - PMC - PubMed
    1. Mora C, Navarro JF. Inflammation and diabetic nephropathy. Curr Diab Rep 2006; 6: 463–468. - PubMed
    1. Navarro‐González JF, Mora‐Fernández C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008; 19: 433–442. - PubMed
    1. Dressler RL. Antihypertensive agents for prevention of diabetic nephropathy. Am Fam Physician 2006; 74: 77–79. - PubMed

Grants and funding